Found 134 matching trials
Safety, Tolerability and Efficacy of PfSPZ Vaccine Against Heterologous CHMI in US Malaria naïve Adults PHASE1 This is a randomized, double blind, placebo-controlled, single site, trial ...
Show More Location
Fred Hutchinson Cancer Research Center
Learn More & Join Trial
Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants in India PHASE3 The purpose of this study is to assess the safety, tolerability and immunog...
Show More Location
Multiple Locations
Learn More & Join Trial
Tolerability and Immunogenicity Study of Fluval AB Influenza Vaccine in Adults and Elderly Persons PHASE4 The purpose of this study is to determine the immunogenicity and tolerabili...
Show More Location
Family Doctor's Office
Learn More & Join Trial
Clinical Study to Assess the Immunogenicity and Safety of Hexavalent Vaccine Containing Reduced Dose IPV PHASE3 In 2012, the World Health Assembly (WHA) endorsed the proposed Polio Endgam...
Show More Location
International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B), Kamalapur Field office, Lichubagan Rd
Learn More & Join Trial
Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007) PHASE3 This study will determine whether participants who receive the vaccine V419...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate the Immunogenicity of Quadrivalent Live Attenuated Influenza Vaccine (LAIV) in Children PHASE3 The primary objective of this study is to demonstrate the immunologic nonin...
Show More Learn More & Join Trial
A Study to Assess the Safety and Immunogenicity of M-001 Influenza Vaccine as a Primer to TIV in Elderly Volunteers PHASE2 "Multimeric-001" (M-001) has been recently developed, containing conserved,...
Show More Location
Hadassah medical center
Learn More & Join Trial
Immunity Against Varicella in Pediatric Orthotopic Liver Transplantation Recipients PHASE2 Varicella is a vaccine-preventable disease, which can be severe in immunosu...
Show More Location
Children's Hospital of Geneva (HUG)
Learn More & Join Trial
Immunogenicity and Safety of AdCLD-CoV19-1 OMI As a Booster: a COVID-19 Preventive Vaccine in Healthy Volunteers PHASE3 The immunogenicity and safety of AdCLD-CoV19-1 OMI (5.0x10\^10 VP (0.5 mL)/...
Show More Status
Active Not Recruiting
Location
The Medical City-Iloilo
Learn More & Join Trial
A Phase Il of a Therapeutic, Recombinant, Biologically Active HIV-1 Tat Protein Vaccine in HIV-Infected, Anti-Tat Negative, ARV-Treated Adult Volunteers PHASE2 Tat is a key HIV regulatory protein produced very early after infection, pr...
Show More Location
Medunsa Clinical Research Unit (MeCRU)
Learn More & Join Trial